Authors:	Pradhan, Swetalina Schwartz, Robert Patil, Anant Grabbe, Stephan Goldust, Mohamad
Title:	Treatment options for leishmaniasis
Online publication date:	7-Sep-2022
Year of first publication:	2022
Language:	english
Abstract:	Leishmaniasis is broadly classified into three types: cutaneous, mucocutaneous and visceral. The visceral form is most dangerous and can result in death. Although leishmaniasis is an ancient disease, its treatment is still challenging. Several drugs, differing in their cost, toxicity, treatment duration and emergence of drug resistance, are used for different types of leishmaniasis. To overcome these limitations, the search for newer drugs and other treatments continues. In this article, we discuss conventional drugs, other treatments, including newer options such as immunotherapy and immunochemotherapy, and future prospects for leishmaniasis treatment.
DDC:	610 Medizin 610 Medical sciences
Institution:	Johannes Gutenberg-Universität Mainz
Department:	FB 04 Medizin
Place:	Mainz
ROR:	https://ror.org/023b0x485
DOI:	http://doi.org/10.25358/openscience-7691
Version:	Published version
Publication type:	Zeitschriftenaufsatz
License:	CC BY
Information on rights of use:	https://creativecommons.org/licenses/by/4.0/
Journal:	Clinical and experimental dermatology 47 3
Pages or article number:	516 521
Publisher:	Wiley-Blackwell
Publisher place:	Oxford u.a
Issue date:	2022
ISSN:	1365-2230
Publisher DOI:	10.1111/ced.14919
Appears in collections:	JGU-Publikationen